Hypertension Management

Introduction to Hypertension Management

• Hypertension management requires careful consideration of blood pressure goals, with an initial goal of reducing systolic blood pressure (SBP) by no more than 25% within the first hour, then to 160/100 mmHg within the next 2-6 hours, and finally to normal over the following 24-48 hours, as recommended by the American Heart Association and the European Society of Cardiology 1, 2, 3, 4

Medication Recommendations

• The American College of Cardiology recommends nicardipine or clevidipine as effective alternatives for hypertensive urgency management 1
• For acute aortic dissection, the American College of Cardiology suggests esmolol + nitroprusside/nitroglycerin or labetalol 1
• In cases of acute pulmonary edema, the American College of Cardiology recommends nitroglycerin, nitroprusside, or clevidipine 1
• For acute coronary syndromes, the American College of Cardiology suggests nitroglycerin, esmolol, labetalol, or nicardipine 1
• The American College of Cardiology recommends hydralazine, labetalol, or nicardipine for eclampsia/preeclampsia 1
• The European Society of Cardiology guidelines recommend IV labetalol, oral methyldopa, or nifedipine only for severe hypertension in specific contexts such as pregnancy, with IV hydralazine as a second-line option 5
• The American Heart Association recommends labetalol as the first-line IV medication for most hypertensive urgencies, with nicardipine, nitroprusside, and clevidipine as effective alternatives depending on the clinical scenario 1
• The following table outlines the preferred medications for different clinical scenarios:

Medication Administration

• Labetalol can be administered as an initial 20 mg IV bolus over 2 minutes, followed by additional doses of 40-80 mg every 10 minutes as needed, up to 300 mg total, or as a continuous infusion at 2 mg/min 1
• Nicardipine can be started at 5 mg/h IV, increasing by 2.5 mg/h every 5 minutes to a maximum of 15 mg/h 2
• Clevidipine can be initiated at 1-2 mg/h, doubling every 90 seconds until approaching target BP, and is particularly useful in acute renal failure and perioperative hypertension 1
• Nitroprusside can be administered at 0.25-10 μg/kg/min as an IV infusion, with immediate onset and short duration, but requires continuous BP monitoring and has a risk of cyanide toxicity with prolonged use 6

Special Considerations

• Nifedipine should not be administered to patients with systolic blood pressure below 90 mmHg due to the risk of dangerous hypotension and potential cardiovascular collapse, as recommended by the American College of Cardiology 7, 8
• Patients with acute ischemic stroke eligible for thrombolytic therapy should have their blood pressure carefully managed, and nifedipine is not recommended due to its potential for precipitous drops in blood pressure; instead, labetalol, nicardipine, or nitropaste are preferred agents 8, 9
• Nifedipine is potentially harmful in patients with hypertrophic cardiomyopathy who have outflow tract obstruction, regardless of blood pressure, as warned by the American Heart Association 7
• Elderly patients are more susceptible to hypotension and should be considered for lower starting doses 10
• Volume-depleted patients should have their volume status corrected before administering nifedipine 10
• Combining nifedipine with other vasodilators can cause synergistic hypotension, and caution should be exercised 10

Administration via G-Tube

• The American Gastroenterological Association recommends administering medications at least 1 hour before or 2 hours after enteral nutrition when possible, and for continuous tube feedings, consider pausing the feeding 30 minutes before and after medication administration, to ensure efficacy and minimize interactions 11
• The American Society of Health-System Pharmacists recommends using a pill crusher or mortar and pestle to create a fine powder, and crushing one medication at a time to avoid interactions, to ensure safe administration of medications via G-tube 11
• Mix crushed medication with 15-30 mL of water, flush G-tube with 15-30 mL of water before medication administration, administer each medication separately, flush with 15-30 mL of water between medications, and flush with 30-60 mL of water after the last medication, to prevent clogging and ensure delivery of the medication 11
• Monitor blood pressure regularly to ensure efficacy of crushed medications, and watch for tube occlusion, which may occur with inadequately crushed or diluted medications, to minimize complications and ensure effective blood pressure control 11

Clinical Presentations

• The following table outlines the first-line treatment and alternative options for different clinical presentations:

2

• Avoid excessive reduction of blood pressure that may precipitate renal, cerebral, or coronary ischemia, as warned by the American College of Cardiology and the American Heart Association 3, 12

Asymptomatic Severe Hypertension

• The American College of Emergency Physicians recommends prioritizing outpatient follow-up over aggressive immediate treatment in asymptomatic severe hypertension 10